<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CAT</journal-id>
<journal-id journal-id-type="hwp">spcat</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Appl Thromb Hemost</journal-id>
<journal-title>Clinical and Applied Thrombosis/Hemostasis</journal-title>
<issn pub-type="ppub">1076-0296</issn>
<issn pub-type="epub">1938-2723</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1076029611405036</article-id>
<article-id pub-id-type="publisher-id">10.1177_1076029611405036</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letter to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Glanzmann Thrombasthenia in Pregnancy</article-title>
<subtitle>The Value of a Probing Bleeding History</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sharma</surname>
<given-names>Prashant</given-names>
</name>
<degrees>MD, DNB, DM</degrees>
<xref ref-type="aff" rid="aff1-1076029611405036">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gogia</surname>
<given-names>Sanjay</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-1076029611405036">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zafar</surname>
<given-names>Mir Sadaqat Hassan</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1076029611405036">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saraf</surname>
<given-names>Amrita</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1076029611405036">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bhargava</surname>
<given-names>Manorama</given-names>
</name>
<degrees>MD, FAMS</degrees>
<xref ref-type="aff" rid="aff1-1076029611405036">1</xref>
<xref ref-type="corresp" rid="corresp1-1076029611405036"/>
</contrib>
</contrib-group>
<aff id="aff1-1076029611405036"><label>1</label>Department of Hematology, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, India</aff>
<aff id="aff2-1076029611405036"><label>2</label>Department of Internal Medicine, Max Hospital, Pitam Pura, New Delhi, India</aff>
<author-notes>
<corresp id="corresp1-1076029611405036">Manorama Bhargava, Hematology Department, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi 110060, India. Email: <email>mbhemat@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2012</year>
</pub-date>
<volume>18</volume>
<issue>1</issue>
<fpage>110</fpage>
<lpage>112</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January/Febraury 2012</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="section1-1076029611405036">
<title>Dear Editor,</title>
<p>A 28-year-old lady with 18<sup>+4</sup> weeks pregnancy was referred to medicine and hematology when her obstetrician elicited a history of mucocutaneous bleeding, initially of uncertain significance. Although insistent that she was “fine” with only “heavy periods,” the clinician’s suspicions were aroused when the patient volunteered that she had once required hospitalization following severe menorrhagia and received 2 units of packed red cells due to blood loss 3 years ago. On detailed probing, it also emerged that excessive bleeding was, in fact, present since early childhood and although very intermittent, tended to be severe in nature. As a 4-year-old, she had been hospitalized and transfused blood following uncontrolled bleeding from a tongue injury received during playtime. At that time, she had been investigated, but old papers were unavailable and her parents had been reassured that she would most likely grow out of the problem. There was no history of bleeding from the umbilical cord stump, no history of consanguinity or any similar illness in her family, and no history of bleeding from a site other than skin, oral mucosa, or menorrhagia.</p>
<p>Despite being currently complaint-free and the screening laboratory studies (platelet count, prothrombin time, activated partial thromboplastin time, fibrinogen and thrombin time, <xref ref-type="table" rid="table1-1076029611405036">Table 1</xref>
) returning to normal, her care providers decided to proceed with further testing.</p>
<table-wrap id="table1-1076029611405036" position="float">
<label>Table 1.</label>
<caption>
<p>Routine Hematological and Screening Coagulation Parameters</p>
</caption>
<graphic alternate-form-of="table1-1076029611405036" xlink:href="10.1177_1076029611405036-table1.tif"/>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Results</th>
<th>Reference Range</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hemoglobin (g/dL)</td>
<td>16.8</td>
<td>12-16</td>
</tr>
<tr>
<td>Total WBC Count (per μL)</td>
<td>10,800</td>
<td>4,000-10,000</td>
</tr>
<tr>
<td>Platelet Count (per μL)</td>
<td>1,44,000</td>
<td>1,50,000-4,00,000</td>
</tr>
<tr>
<td>Mean Platelet Volume (fl)</td>
<td>8.8</td>
<td>7.0-10.5</td>
</tr>
<tr>
<td>Prothrombin time (s)</td>
<td>12.6</td>
<td>10.0-13.2</td>
</tr>
<tr>
<td>Activated partial thromboplastin time (s)</td>
<td>32.4</td>
<td>25.1-36.7</td>
</tr>
<tr>
<td>Thrombin time</td>
<td>21.3</td>
<td>19.2-23.8</td>
</tr>
<tr>
<td>Fibrinogen level (g/L)</td>
<td>4.207</td>
<td>2.0-4.0</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Her von Willebrand antigen level was normal for blood group. Clot retraction at 1 hour was deficient and yielded a ratio of expressed serum volume to total volume of 20% (expected normal value &gt;40%).<sup><xref ref-type="bibr" rid="bibr1-1076029611405036">1</xref></sup> Light transmission platelet aggregometry (Chronolog Corp, Pennsylvania, USA) revealed virtually absent platelet aggregation responses to arachidonic acid (0.75 mmol/L), collagen (2 μg/mL), adenosine diphosphate (10 μmol/L), and epinephrine (10 μmol/L). Responses to ristocetin (high dose, 1.25 mg/mL and low dose, 0.25 mg/mL) were normal (<xref ref-type="fig" rid="fig1-1076029611405036">Figure 1A, B, and C</xref> and <xref ref-type="table" rid="table2-1076029611405036">Table 2</xref>
). The diagnosis of Glanzmann thrombasthenia (GT), type 2 was confirmed when flow cytometric studies showed reduced surface expression of gpIIb (CD41) on her platelets.</p>
<fig id="fig1-1076029611405036" position="float">
<label>Figure 1.</label>
<caption>
<p>A, Markedly reduced aggregation with arachidonic acid and collagen. B, Markedly reduced aggregation with adenosine diphosphate and adrenaline. C, Normal aggregation responses with high- and low-dose ristocetin.</p>
</caption>
<graphic xlink:href="10.1177_1076029611405036-fig1.tif"/>
</fig>
<table-wrap id="table2-1076029611405036" position="float">
<label>Table 2.</label>
<caption>
<p>Light Transmission Platelet Aggregometry Results</p>
</caption>
<graphic alternate-form-of="table2-1076029611405036" xlink:href="10.1177_1076029611405036-table2.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">Agonist</th>
<th align="center" colspan="2">% Aggregation</th>
<th rowspan="2">Normal Range of Laboratory</th>
<th rowspan="2">Interpretation of Response</th>
</tr>
<tr>
<th>Test</th>
<th>Control</th>
</tr>
</thead>
<tbody>
<tr>
<td>ADP 10 μmol/L</td>
<td>10</td>
<td>72</td>
<td>71%-88%</td>
<td>Deficient</td>
</tr>
<tr>
<td>Epinephrine 10 μmol/L</td>
<td>00</td>
<td>67</td>
<td>71%-90%</td>
<td>Deficient</td>
</tr>
<tr>
<td>Collagen 2 μg/mL</td>
<td>01</td>
<td>75</td>
<td>70%-94%</td>
<td>Deficient</td>
</tr>
<tr>
<td>Arachidonic acid 0.75 mmol/L</td>
<td>03</td>
<td>81</td>
<td>72%-99%</td>
<td>Deficient</td>
</tr>
<tr>
<td>Ristocetin 1.25 mg/mL</td>
<td>86</td>
<td>87</td>
<td>87%-102%</td>
<td>Normal</td>
</tr>
<tr>
<td>Ristocetin 0.25 mg/mL</td>
<td>01</td>
<td>02</td>
<td>0%-4%</td>
<td>Normal</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>She had an uneventful pregnancy under heightened medical watchfulness. She was already immunized for hepatitis B and her antibody titers were ascertained. Delivery was at term and through an elective lower segment caesarean section (LSCS). One unit of the single donor platelets kept ready was required to effectively control postoperative oozing, at a near-normal platelet count. The neonate had a normal platelet count. Both the mother and the baby were complaint-free at last follow-up, 3 months post-LSCS.</p>
<p>Although rare overall, GT is the commonest inherited platelet function defect found in Indian women with menorrhagia.<sup><xref ref-type="bibr" rid="bibr2-1076029611405036">2</xref></sup> Patients with this autosomal recessive disorder, resulting from a deficiency or defect in the platelet surface glycoprotein IIb/IIIa (integrin αIIbβ3) or its regulatory elements usually display a severe bleeding phenotype.<sup><xref ref-type="bibr" rid="bibr3-1076029611405036">3</xref></sup> Diagnosis is based on deficient platelet aggregometric responses to multiple agents, with normal agglutination in response to ristocetin.<sup><xref ref-type="bibr" rid="bibr3-1076029611405036">3</xref></sup> Similar patterns may be obtained in afibrinogenemia,<sup><xref ref-type="bibr" rid="bibr4-1076029611405036">4</xref></sup> but this was excluded by a normal thrombin time and fibrinogen levels in our case.</p>
<p>Severe bleeders, especially in India, may go undiagnosed for prolonged periods of time due to the nonavailability or nonaffordability of specialized tests.<sup><xref ref-type="bibr" rid="bibr5-1076029611405036">5</xref></sup> Women may underestimate the severity of their symptoms<sup><xref ref-type="bibr" rid="bibr6-1076029611405036">6</xref></sup> and the suspicion of chronic ill health too may be socially detrimental.<sup><xref ref-type="bibr" rid="bibr7-1076029611405036">7</xref></sup> Physicians may be reassured by a normal coagulation screen or may be unaware of the significance of rare inherited platelet function disorders as well as of the appropriate tests to order.<sup><xref ref-type="bibr" rid="bibr8-1076029611405036">8</xref>,<xref ref-type="bibr" rid="bibr9-1076029611405036">9</xref></sup> This may be compounded by the lack of uniformity among laboratories in the methodologies employed for platelet function testing and their quality control.<sup><xref ref-type="bibr" rid="bibr10-1076029611405036">10</xref></sup>
</p>
<p>Apart from adding to the published literature on successful obstetric outcomes in patients with GT, this case serves as a striking reminder of the life-saving importance of a high index of suspicion for a potential bleeding disorder in patients facing major hemostatic challenges like parturition. Timely diagnosis of inherited thrombocytopathy by an alert clinician likely averted catastrophic hemorrhage post-LSCS, a time when an accurate primary diagnosis would have been virtually impossible and platelet transfusion therapy would not have been considered. A detailed bleeding history regardless of the coagulation screen results and apparent asymptomatic state remains an excellent “diagnostic test” for bleeding disorders.<sup><xref ref-type="bibr" rid="bibr11-1076029611405036">11</xref></sup>
</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-1076029611405036">
<p>This case was presented in the bimonthly Laboratory Meeting of the Sir Ganga Ram Hospital, New Delhi, on March 18, 2010.</p>
</fn>
<fn fn-type="conflict" id="fn2-1076029611405036">
<p>The author(s) declared no conflicts of interest with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-1076029611405036">
<p>The author(s) received no financial support for the research and/or authorship of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1076029611405036">
<label>1</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Kitchen</surname><given-names>S</given-names></name><name><surname>McCraw</surname><given-names>A</given-names></name><name><surname>Echenagucia</surname><given-names>M</given-names></name></person-group> on <collab collab-type="author">behalf of the WFH Laboratory Sciences Committee</collab>. <article-title>Platelet function testing</article-title>. In: <source>Diagnosis of Hemophilia and Other Bleeding Disorders: A Laboratory Manual</source>. <edition>2nd ed</edition>. <year>2010</year>;<fpage>125</fpage>. <comment>Available full-text at the World Federation of Hemophilia website:</comment> <ext-link ext-link-type="uri" xlink:href="http://www.wfh.org/2/docs/Publications/Diagnosis_and_Treatment/Lab_Manual2010/Lab_Manual_Section-39.pdf">http://www.wfh.org/2/docs/Publications/Diagnosis_and_Treatment/Lab_Manual2010/Lab_Manual_Section-39.pdf</ext-link>. <comment>Accessed January 23, 2010</comment>.</citation>
</ref>
<ref id="bibr2-1076029611405036">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saxena</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Kashyap</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Choudhry</surname>
<given-names>VP</given-names>
</name>
<name>
<surname>Bhargava</surname>
<given-names>M.</given-names>
</name>
</person-group> <article-title>Inherited bleeding disorders in Indian women with menorrhagia</article-title>. <source>Haemophilia</source>. <year>2003</year>;<volume>9</volume>(<issue>2</issue>):<fpage>193</fpage>–<lpage>196</lpage>.</citation>
</ref>
<ref id="bibr3-1076029611405036">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kannan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>R.</given-names>
</name>
</person-group> <article-title>Glanzmann’s thrombasthenia: an overview</article-title>. <source>Clin Appl Thromb Hemost</source>. <year>2009</year>;<volume>15</volume>(<issue>2</issue>):<fpage>152</fpage>–<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr4-1076029611405036">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J.</given-names>
</name>
</person-group> <article-title>Fibrinogen and platelets in the primary arrest of bleeding</article-title>. <source>N Engl J Med</source>. <year>1971</year>;<volume>285</volume>(<issue>7</issue>):<fpage>369</fpage>.</citation>
</ref>
<ref id="bibr5-1076029611405036">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kishore</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shukla</surname>
<given-names>J.</given-names>
</name>
</person-group> <article-title>Prevalence and spectrum of von Willebrand disease in Eastern Uttar Pradesh</article-title>. <source>Indian J Pathol Microbiol</source>. <year>2010</year>;<volume>53</volume>(<issue>3</issue>):<fpage>492</fpage>–<lpage>495</lpage>.</citation>
</ref>
<ref id="bibr6-1076029611405036">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siboni</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Spreafico</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Calò</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Gynaecological and obstetrical problems in women with different bleeding disorders</article-title>. <source>Haemophilia</source>. <year>2009</year>;<volume>15</volume>(<issue>6</issue>):<fpage>1291</fpage>–<lpage>1299</lpage>.</citation>
</ref>
<ref id="bibr7-1076029611405036">
<label>7</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Dalal</surname><given-names>AK</given-names></name><name><surname>Biswas</surname><given-names>G. </given-names></name></person-group> <article-title>Self-construal among healthy and chronically sick women. psychological studies</article-title>. <year>2009</year>;<fpage>54</fpage>. <ext-link ext-link-type="uri" xlink:href="http://ipi.org.in/texts/ajit//dalal-self-construal.pdf">http://ipi.org.in/texts/ajit//dalal-self-construal.pdf</ext-link>. <comment>Accessed November 16, 2010</comment>.</citation>
</ref>
<ref id="bibr8-1076029611405036">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Colvin</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Letsky</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Rivers</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>R.</given-names>
</name>
</person-group> <article-title>Investigation and management of haemorrhagic disorders in pregnancy. Haemostasis and Thrombosis Task Force</article-title>. <source>J Clin Pathol</source>. <year>1994</year>;<volume>47</volume>(<issue>2</issue>):<fpage>100</fpage>–<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr9-1076029611405036">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chee</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Greaves</surname>
<given-names>M.</given-names>
</name>
</person-group> <article-title>Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology</article-title>. <source>Br J Haematol</source>. <year>2008</year>;<volume>140</volume>(<issue>5</issue>):<fpage>496</fpage>–<lpage>504</lpage>.</citation>
</ref>
<ref id="bibr10-1076029611405036">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jennings</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Woods</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Kitchen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>ID.</given-names>
</name>
</person-group> <article-title>Platelet function testing: practice among UK National External Quality Assessment Scheme for Blood Coagulation participants, 2006</article-title>. <source>J Clin Pathol</source>. <year>2008</year>;<volume>61</volume>(<issue>8</issue>):<fpage>950</fpage>–<lpage>954</lpage>.</citation>
</ref>
<ref id="bibr11-1076029611405036">
<label>11</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Merrick</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Macfadyen</surname>
<given-names>BV.</given-names>
</name>
</person-group> <article-title>Surgical bleeding and blood replacement</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Lawrence</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Dayton</surname>
<given-names>MT</given-names>
</name>
</person-group> (Eds.), <source>Essentials of General Surgery</source>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lippincott Williams and Wilkins</publisher-name>; <year>2006</year>:<fpage>93</fpage>.</citation></ref>
</ref-list>
</back>
</article>